Analgesics - Americas

  • Americas
  • In 2024, revenue in the Analgesics market in Americas amounts to US$11.01bn.
  • It is projected to experience an annual growth rate of 5.31% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue with US$7,243.00m in 2024.
  • Taking into account the total population, per person revenues of US$10.83 are generated in 2024.
  • In the Americas, the demand for over-the-counter analgesics is driven by a strong emphasis on self-care and a preference for accessible and affordable pain relief options.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Americas is witnessing significant growth due to various factors such as changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Analgesics market in Americas are shifting towards natural and organic products. Consumers are becoming more health-conscious and are seeking alternatives to traditional pain relief medications. This has led to an increased demand for herbal and homeopathic remedies in the region. Additionally, there is a growing preference for products that offer long-lasting relief and have fewer side effects. Trends in the market include the rise of e-commerce and online sales channels. Consumers are increasingly turning to online platforms to purchase Analgesics products, due to the convenience and wide range of options available. This trend is particularly prominent in countries such as the United States and Canada, where online shopping is well-established. Furthermore, there is a growing trend towards personalized medicine, with consumers seeking customized pain relief solutions based on their individual needs and preferences. Local special circumstances in the Analgesics market in Americas vary across different countries. In the United States, for example, there is a high prevalence of chronic pain conditions, which has contributed to the increased demand for Analgesics products. Additionally, the aging population in countries such as Canada and Brazil has resulted in a higher demand for pain relief medications. Furthermore, the regulatory environment in the region plays a significant role in shaping the market. Countries such as the United States have strict regulations on the sale and marketing of Analgesics products, which can impact the availability and accessibility of certain products. Underlying macroeconomic factors also influence the development of the Analgesics market in Americas. Economic growth and rising disposable incomes in countries such as the United States and Canada have led to increased consumer spending on healthcare and wellness products, including Analgesics. Additionally, the prevalence of chronic pain conditions and the aging population contribute to the sustained demand for pain relief medications in the region. Furthermore, advancements in healthcare infrastructure and access to healthcare services have also contributed to the growth of the market. Overall, the Analgesics market in Americas is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and organic products, the rise of e-commerce, and the demand for personalized medicine are driving the market forward. Additionally, factors such as the prevalence of chronic pain conditions, the aging population, and economic growth contribute to the sustained demand for Analgesics products in the region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)